171 related articles for article (PubMed ID: 7851496)
1. Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
Eur J Pharmacol; 1994 Oct; 269(2):201-8. PubMed ID: 7851496
[TBL] [Abstract][Full Text] [Related]
2. 5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine.
Kuoppamäki M; Pälvimäki EP; Syvälahti E; Hietala J
Eur J Pharmacol; 1994 Apr; 255(1-3):91-7. PubMed ID: 8026557
[TBL] [Abstract][Full Text] [Related]
3. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
J Pharmacol Exp Ther; 1993 Mar; 264(3):1262-7. PubMed ID: 8383744
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.
Syvälahti E; Penttilä J; Majasuo H; Pälvimäki EP; Laakso A; Hietala J
Pharmacopsychiatry; 2006 Jan; 39(1):1-8. PubMed ID: 16453246
[TBL] [Abstract][Full Text] [Related]
5. Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment.
Hietala J; Kuonnamäki M; Pälvimäki EP; Laakso A; Majasuo H; Syvälahti E
Psychopharmacology (Berl); 2001 Sep; 157(2):180-7. PubMed ID: 11594443
[TBL] [Abstract][Full Text] [Related]
6. Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
Laakso A; Pälvimäki EP; Kuoppamäki M; Syvälahti E; Hietala J
Neuropsychopharmacology; 1996 Aug; 15(2):143-51. PubMed ID: 8840350
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs.
Kuoppamäki M; Pälvimäki EP; Hietala J; Syvälahti E
Neuropsychopharmacology; 1995 Oct; 13(2):139-50. PubMed ID: 8597525
[TBL] [Abstract][Full Text] [Related]
8. Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation.
Pälvimäki EP; Majasuo H; Kuoppamäki M; Männistö PT; Syvälahti E; Hietala J
Psychopharmacology (Berl); 1998 Mar; 136(2):99-104. PubMed ID: 9551765
[TBL] [Abstract][Full Text] [Related]
9. Modulation of 5-HT1C receptors and phosphoinositide system by ethanol consumption in rat brain and choroid plexus.
Pandey SC; Dubey MP; Piano MR; Schwertz DW; Davis JM; Pandey GN
Eur J Pharmacol; 1993 Sep; 247(1):81-8. PubMed ID: 8258364
[TBL] [Abstract][Full Text] [Related]
10. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
Pälvimäki EP; Majasuo H; Syvälahti E; Hietala J
Pharmacol Res; 2005 May; 51(5):419-25. PubMed ID: 15749456
[TBL] [Abstract][Full Text] [Related]
11. Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics.
Canton H; Verrièle L; Millan MJ
Neurosci Lett; 1994 Nov; 181(1-2):65-8. PubMed ID: 7898773
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.
Kuoppamäki M; Syvälahti E; Hietala J
Eur J Pharmacol; 1993 Apr; 245(2):179-82. PubMed ID: 8387927
[TBL] [Abstract][Full Text] [Related]
15. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
Smith RL; Canton H; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
[TBL] [Abstract][Full Text] [Related]
16. c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.
Zhao C; Li M
Neuroscience; 2010 Apr; 166(4):1043-55. PubMed ID: 20096751
[TBL] [Abstract][Full Text] [Related]
17. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.
Zhao C; Li M
Pharmacol Biochem Behav; 2009 Oct; 93(4):433-42. PubMed ID: 19539643
[TBL] [Abstract][Full Text] [Related]
18. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
Wolf WA; Schutz LJ
J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
[TBL] [Abstract][Full Text] [Related]
19. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium.
Esterle TM; Sanders-Bush E
J Neurosci; 1992 Dec; 12(12):4775-82. PubMed ID: 1334504
[TBL] [Abstract][Full Text] [Related]
20. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]